Harvard Bioscience, Inc.HBIONASDAQ
Loading
Operating Margin Over TimeExpanding
Percentile Rank29
Studio
Year-over-Year Change

Operating income as a percentage of revenue

Percentile
P29
Within normal range
vs 5Y Ago
-3.4x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM-0.73%+89.0%
2024-6.60%-491.0%
20231.69%+127.6%
2022-6.12%-452.1%
20211.74%+702.7%
20200.22%-33.3%
20190.32%-60.2%
20180.81%+921.9%
2017-0.10%+96.5%
2016-2.87%-